Pfizer has informed that the Board of Directors of the Company at its meeting held on May 14, 2013, has appointed S Sridhar as an Additional Director on the Board of the Company with effect from May 14, 2013.The appointment and remuneration of S Sridhar, Whole-time Director will be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
The above information is a part of company’s filings submitted to BSE.